Gonococcal keratitis
ICD-10 A54.33 is a billable code used to indicate a diagnosis of gonococcal keratitis.
Gonococcal keratitis is an ocular infection caused by the bacterium Neisseria gonorrhoeae, which is primarily known for causing gonorrhea, a sexually transmitted infection (STI). This condition typically arises when the bacteria infect the cornea, leading to inflammation and potential damage to the eye. Symptoms may include redness, pain, photophobia, and discharge from the eye. Gonococcal keratitis is considered a medical emergency due to the risk of corneal perforation and vision loss if not treated promptly. The infection can occur in individuals with a history of gonorrhea or through autoinoculation from infected genital secretions. Diagnosis is confirmed through culture or PCR testing of conjunctival swabs. Treatment involves the use of systemic antibiotics, such as ceftriaxone, and topical antibiotics to address the ocular infection. Prompt identification and treatment are crucial to prevent complications, including scarring and permanent vision impairment.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with eye pain, redness, and discharge, particularly those with a history of STIs.
Ensure that all relevant tests are documented to support the diagnosis and treatment.
Comprehensive history of STIs, including previous treatments and sexual partners.
Patients with recurrent gonococcal infections or those presenting with systemic symptoms.
Consideration of co-infections and the need for contact tracing.
Used when a patient presents with symptoms of gonococcal keratitis.
Document the examination findings and any diagnostic tests performed.
Ophthalmologists should ensure comprehensive documentation to support the diagnosis.
Common symptoms include eye pain, redness, photophobia, and purulent discharge from the eye.
Diagnosis is typically made through clinical evaluation and confirmed with culture or PCR testing of conjunctival swabs.
Treatment usually involves systemic antibiotics such as ceftriaxone and topical antibiotics to manage the ocular infection.
